Related Experiment Videos
On the development of rational standards for nuclear response evaluation
1The Cancer Research UK PET Oncology Group, Hammersmith Hospital, London, United Kingdom.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|April 26, 2003
Summary
Standardizing nuclear medicine response evaluation protocols is crucial for accurate cancer therapy assessment. This paper advocates for a decision-analytic approach to developing these essential standards, ensuring value and improved clinical outcomes.
Area of Science:
- Nuclear Medicine
- Oncology
- Medical Imaging
Background:
- Variations in nuclear medicine test protocols significantly impact the accuracy of response evaluation in cancer treatment.
- Standardized methods are necessary to ensure reliable and reproducible results in nuclear oncology.
- The value of medical interventions, including standardized protocols, should be assessed using a concept of 'societal efficacy'.
Purpose of the Study:
- To provide an overview of the existing literature on nuclear medicine response evaluation.
- To promote a decision-analytic framework for the development and synthesis of standardized protocols.
- To highlight the need for linking diagnostic technology evaluations to expected improvements in research and clinical outcomes.
Main Methods:
- Conducted a comprehensive literature search using Medline via the OVID database (1966-January 2002).
- Classified 212 primary human studies based on treatment modality and follow-up timing.
- Identified 125 'before-and-after' studies and over 60 studies utilizing serial positron emission tomography (PET) with fluorodeoxyglucose (FDG).
Main Results:
- The literature search yielded 212 relevant primary studies in humans.
- A significant portion of these studies (125) were formal 'before-and-after' assessments of therapy response.
- Serial FDG-PET imaging was frequently employed in over 60 of the identified studies.
Conclusions:
- Accurate evaluation of new diagnostic technologies in nuclear medicine requires clear links to improved research or clinical outcomes.
- Managing the extensive information generated by these studies necessitates a trans-disciplinary approach.
- Advanced decision-analytic methods are essential for synthesizing standards and ensuring the 'societal efficacy' of nuclear oncology interventions.